Summit Therapeutics
SMMT
#1569
Rank
โ‚น1.313 T
Marketcap
โ‚น1,646
Share price
-5.24%
Change (1 day)
-16.82%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚น1.313 Trillion

As of October 2026 Summit Therapeutics has a market cap of โ‚น1.313 Trillion. This makes Summit Therapeutics the world's 1569th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น1.313 T8.32%
2025โ‚น1.212 T5.23%
2024โ‚น1.152 T656.52%
2023โ‚น152.27 B115.08%
2022โ‚น70.80 B261.89%
2021โ‚น19.56 B-30.81%
2020โ‚น28.27 B268.89%
2019โ‚น7.66 B479.35%
2018โ‚น1.32 B-87.47%
2017โ‚น10.55 B47.62%
2016โ‚น7.15 B-23.64%
2015โ‚น9.36 B

End of Day market cap according to different sources

On Oct 7th, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚น1.385 Trillion
by Nasdaq info icon info icon
โ‚น1.385 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น178.67 B-86.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น21.65 B-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น14.72 B-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚น596.61 B-54.57%๐Ÿ‡บ๐Ÿ‡ธ USA